Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

Introduction Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach strategy for each patient, it is necessary the homogenization of diagnostic and therapeutic interventions, as well as the promo...

Full description

Saved in:
Bibliographic Details
Published inClinical & translational oncology Vol. 26; no. 7; pp. 1647 - 1663
Main Authors Ospina, Aylen Vanessa, Bolufer Nadal, Sergio, Campo-Cañaveral de la Cruz, José Luis, González Larriba, Jose Luis, Macía Vidueira, Ivan, Massutí Sureda, Bartomeu, Nadal, Ernest, Trancho, Florentino Hernando, Álvarez Kindelán, Antonio, Del Barco Morillo, Edel, Bernabé Caro, Reyes, Bosch Barrera, Joaquim, Calvo de Juan, Virginia, Casal Rubio, Joaquin, de Castro, Javier, Cilleruelo Ramos, Ángel, Cobo Dols, Manuel, Dómine Gómez, Manuel, Figueroa Almánzar, Santiago, Garcia Campelo, Rosario, Insa Mollá, Amelia, Jarabo Sarceda, José Ramón, Jiménez Maestre, Unai, López Castro, Rafael, Majem, Margarita, Martinez-Marti, Alex, Martínez Téllez, Elisabeth, Sánchez Lorente, David, Provencio, Mariano
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.07.2024
Subjects
Carcinoma, Non-Small-Cell Lung - pathology
Carcinoma, Non-Small-Cell Lung - therapy
Consensus
Delphi Technique
Humans
Lung Neoplasms - pathology
Lung Neoplasms - therapy
Medicine
Medicine & Public Health
Neoplasm Staging
Oncology
Patient Care Team
Research Article
Spain
Spain
Neoadjuvant
Locally advanced NSCLC
Surgery
Immunotherapy
Expert consensus
Online AccessGet full text
ISSN1699-3055
1699-048X
1699-3055
DOI10.1007/s12094-024-03382-y

Cover

Abstract Introduction Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach strategy for each patient, it is necessary the homogenization of diagnostic and therapeutic interventions, as well as the promotion of the evaluation of patients by a multidisciplinary oncology team. Objective Development of an expert consensus document with suggestions for the approach and treatment of locally advanced NSCLC leaded by Spanish Lung Cancer Group GECP. Methods Between March and July 2023, a panel of 28 experts was formed. Using a mixed technique (Delphi/nominal group) under the guidance of a coordinating group, consensus was reached in 4 phases: 1. Literature review and definition of discussion topics 2. First round of voting 3. Communicating the results and second round of voting 4. Definition of conclusions in nominal group meeting. Responses were consolidated using medians and interquartile ranges. The threshold for agreement was defined as 85% of the votes. Results New and controversial situations regarding the diagnosis and management of locally advanced NSCLC were analyzed and reconciled based on evidence and clinical experience. Discussion issues included: molecular diagnosis and biomarkers, radiologic and surgical diagnosis, mediastinal staging, role of the multidisciplinary thoracic committee, neoadjuvant treatment indications, evaluation of response to neoadjuvant treatment, postoperative evaluation, and follow-up. Conclusions Consensus clinical suggestions were generated on the most relevant scenarios such as diagnosis, staging and treatment of locally advanced lung cancer, which will serve to support decision-making in daily practice.
AbstractList Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach strategy for each patient, it is necessary the homogenization of diagnostic and therapeutic interventions, as well as the promotion of the evaluation of patients by a multidisciplinary oncology team. Development of an expert consensus document with suggestions for the approach and treatment of locally advanced NSCLC leaded by Spanish Lung Cancer Group GECP. Between March and July 2023, a panel of 28 experts was formed. Using a mixed technique (Delphi/nominal group) under the guidance of a coordinating group, consensus was reached in 4 phases: 1. Literature review and definition of discussion topics 2. First round of voting 3. Communicating the results and second round of voting 4. Definition of conclusions in nominal group meeting. Responses were consolidated using medians and interquartile ranges. The threshold for agreement was defined as 85% of the votes. New and controversial situations regarding the diagnosis and management of locally advanced NSCLC were analyzed and reconciled based on evidence and clinical experience. Discussion issues included: molecular diagnosis and biomarkers, radiologic and surgical diagnosis, mediastinal staging, role of the multidisciplinary thoracic committee, neoadjuvant treatment indications, evaluation of response to neoadjuvant treatment, postoperative evaluation, and follow-up. Consensus clinical suggestions were generated on the most relevant scenarios such as diagnosis, staging and treatment of locally advanced lung cancer, which will serve to support decision-making in daily practice.
Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach strategy for each patient, it is necessary the homogenization of diagnostic and therapeutic interventions, as well as the promotion of the evaluation of patients by a multidisciplinary oncology team.INTRODUCTIONRecent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach strategy for each patient, it is necessary the homogenization of diagnostic and therapeutic interventions, as well as the promotion of the evaluation of patients by a multidisciplinary oncology team.Development of an expert consensus document with suggestions for the approach and treatment of locally advanced NSCLC leaded by Spanish Lung Cancer Group GECP.OBJECTIVEDevelopment of an expert consensus document with suggestions for the approach and treatment of locally advanced NSCLC leaded by Spanish Lung Cancer Group GECP.Between March and July 2023, a panel of 28 experts was formed. Using a mixed technique (Delphi/nominal group) under the guidance of a coordinating group, consensus was reached in 4 phases: 1. Literature review and definition of discussion topics 2. First round of voting 3. Communicating the results and second round of voting 4. Definition of conclusions in nominal group meeting. Responses were consolidated using medians and interquartile ranges. The threshold for agreement was defined as 85% of the votes.METHODSBetween March and July 2023, a panel of 28 experts was formed. Using a mixed technique (Delphi/nominal group) under the guidance of a coordinating group, consensus was reached in 4 phases: 1. Literature review and definition of discussion topics 2. First round of voting 3. Communicating the results and second round of voting 4. Definition of conclusions in nominal group meeting. Responses were consolidated using medians and interquartile ranges. The threshold for agreement was defined as 85% of the votes.New and controversial situations regarding the diagnosis and management of locally advanced NSCLC were analyzed and reconciled based on evidence and clinical experience. Discussion issues included: molecular diagnosis and biomarkers, radiologic and surgical diagnosis, mediastinal staging, role of the multidisciplinary thoracic committee, neoadjuvant treatment indications, evaluation of response to neoadjuvant treatment, postoperative evaluation, and follow-up.RESULTSNew and controversial situations regarding the diagnosis and management of locally advanced NSCLC were analyzed and reconciled based on evidence and clinical experience. Discussion issues included: molecular diagnosis and biomarkers, radiologic and surgical diagnosis, mediastinal staging, role of the multidisciplinary thoracic committee, neoadjuvant treatment indications, evaluation of response to neoadjuvant treatment, postoperative evaluation, and follow-up.Consensus clinical suggestions were generated on the most relevant scenarios such as diagnosis, staging and treatment of locally advanced lung cancer, which will serve to support decision-making in daily practice.CONCLUSIONSConsensus clinical suggestions were generated on the most relevant scenarios such as diagnosis, staging and treatment of locally advanced lung cancer, which will serve to support decision-making in daily practice.
Introduction Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach strategy for each patient, it is necessary the homogenization of diagnostic and therapeutic interventions, as well as the promotion of the evaluation of patients by a multidisciplinary oncology team. Objective Development of an expert consensus document with suggestions for the approach and treatment of locally advanced NSCLC leaded by Spanish Lung Cancer Group GECP. Methods Between March and July 2023, a panel of 28 experts was formed. Using a mixed technique (Delphi/nominal group) under the guidance of a coordinating group, consensus was reached in 4 phases: 1. Literature review and definition of discussion topics 2. First round of voting 3. Communicating the results and second round of voting 4. Definition of conclusions in nominal group meeting. Responses were consolidated using medians and interquartile ranges. The threshold for agreement was defined as 85% of the votes. Results New and controversial situations regarding the diagnosis and management of locally advanced NSCLC were analyzed and reconciled based on evidence and clinical experience. Discussion issues included: molecular diagnosis and biomarkers, radiologic and surgical diagnosis, mediastinal staging, role of the multidisciplinary thoracic committee, neoadjuvant treatment indications, evaluation of response to neoadjuvant treatment, postoperative evaluation, and follow-up. Conclusions Consensus clinical suggestions were generated on the most relevant scenarios such as diagnosis, staging and treatment of locally advanced lung cancer, which will serve to support decision-making in daily practice.
Author Nadal, Ernest
Provencio, Mariano
Casal Rubio, Joaquin
Sánchez Lorente, David
Trancho, Florentino Hernando
Insa Mollá, Amelia
Majem, Margarita
Campo-Cañaveral de la Cruz, José Luis
Jiménez Maestre, Unai
Martinez-Marti, Alex
Cobo Dols, Manuel
Bernabé Caro, Reyes
Figueroa Almánzar, Santiago
González Larriba, Jose Luis
Del Barco Morillo, Edel
Bosch Barrera, Joaquim
Garcia Campelo, Rosario
Dómine Gómez, Manuel
Cilleruelo Ramos, Ángel
Bolufer Nadal, Sergio
de Castro, Javier
Calvo de Juan, Virginia
Ospina, Aylen Vanessa
Macía Vidueira, Ivan
Jarabo Sarceda, José Ramón
Martínez Téllez, Elisabeth
Massutí Sureda, Bartomeu
López Castro, Rafael
Álvarez Kindelán, Antonio
Author_xml – sequence: 1
  givenname: Aylen Vanessa
  surname: Ospina
  fullname: Ospina, Aylen Vanessa
  email: avospina@hotmail.com
  organization: Head of the Oncology Department at the Hospital Universitario Puerta de Hierro. Full Professor of Medicine, Universidad Autónoma de Madrid
– sequence: 2
  givenname: Sergio
  surname: Bolufer Nadal
  fullname: Bolufer Nadal, Sergio
  organization: H. General Universitario Dr. Balmis de Alicante
– sequence: 3
  givenname: José Luis
  surname: Campo-Cañaveral de la Cruz
  fullname: Campo-Cañaveral de la Cruz, José Luis
  organization: Hospital Universitario Puerta de Hierro Majadahonda
– sequence: 4
  givenname: Jose Luis
  surname: González Larriba
  fullname: González Larriba, Jose Luis
  organization: H. Clínico San Carlos
– sequence: 5
  givenname: Ivan
  surname: Macía Vidueira
  fullname: Macía Vidueira, Ivan
  organization: H. Universitari de Bellvitge, L’Hospitalet de Llobregat
– sequence: 6
  givenname: Bartomeu
  surname: Massutí Sureda
  fullname: Massutí Sureda, Bartomeu
  organization: H. Universitario Dr Balmis Alicante
– sequence: 7
  givenname: Ernest
  surname: Nadal
  fullname: Nadal, Ernest
  organization: ICO Bellvitge, Hospitalet
– sequence: 8
  givenname: Florentino Hernando
  surname: Trancho
  fullname: Trancho, Florentino Hernando
  organization: H. Clínico San Carlos
– sequence: 9
  givenname: Antonio
  surname: Álvarez Kindelán
  fullname: Álvarez Kindelán, Antonio
  organization: H. Reina Sofía
– sequence: 10
  givenname: Edel
  surname: Del Barco Morillo
  fullname: Del Barco Morillo, Edel
  organization: H. Universitario de Salamanca
– sequence: 11
  givenname: Reyes
  surname: Bernabé Caro
  fullname: Bernabé Caro, Reyes
  organization: Hospital Virgen Del Rocio
– sequence: 12
  givenname: Joaquim
  surname: Bosch Barrera
  fullname: Bosch Barrera, Joaquim
  organization: ICO, H. Universitario Dr. Josep Trueta
– sequence: 13
  givenname: Virginia
  surname: Calvo de Juan
  fullname: Calvo de Juan, Virginia
  organization: Hospital Universitario Puerta de Hierro Majadahonda
– sequence: 14
  givenname: Joaquin
  surname: Casal Rubio
  fullname: Casal Rubio, Joaquin
  organization: H. Universitario Alvaro Cunqueiro
– sequence: 15
  givenname: Javier
  surname: de Castro
  fullname: de Castro, Javier
  organization: H. Universitario La Paz
– sequence: 16
  givenname: Ángel
  surname: Cilleruelo Ramos
  fullname: Cilleruelo Ramos, Ángel
  organization: H. Clínico Universitario de Valladolid
– sequence: 17
  givenname: Manuel
  surname: Cobo Dols
  fullname: Cobo Dols, Manuel
  organization: H. Regional Universitario Málaga
– sequence: 18
  givenname: Manuel
  surname: Dómine Gómez
  fullname: Dómine Gómez, Manuel
  organization: H. Universitario Fundación Jiménez Díaz
– sequence: 19
  givenname: Santiago
  surname: Figueroa Almánzar
  fullname: Figueroa Almánzar, Santiago
  organization: H. Clínico Universitario de Valencia
– sequence: 20
  givenname: Rosario
  surname: Garcia Campelo
  fullname: Garcia Campelo, Rosario
  organization: H. Universitario A Coruña
– sequence: 21
  givenname: Amelia
  surname: Insa Mollá
  fullname: Insa Mollá, Amelia
  organization: H. Clínico Universitario de Valencia
– sequence: 22
  givenname: José Ramón
  surname: Jarabo Sarceda
  fullname: Jarabo Sarceda, José Ramón
  organization: H. Clínico San Carlos
– sequence: 23
  givenname: Unai
  surname: Jiménez Maestre
  fullname: Jiménez Maestre, Unai
  organization: H. Universitario Cruces
– sequence: 24
  givenname: Rafael
  surname: López Castro
  fullname: López Castro, Rafael
  organization: H. Clínico Universitario de Valladolid
– sequence: 25
  givenname: Margarita
  surname: Majem
  fullname: Majem, Margarita
  organization: H. de la Santa Creu i Sant Pau
– sequence: 26
  givenname: Alex
  surname: Martinez-Marti
  fullname: Martinez-Marti, Alex
  organization: H. Universitari Vall D’hebrón
– sequence: 27
  givenname: Elisabeth
  surname: Martínez Téllez
  fullname: Martínez Téllez, Elisabeth
  organization: H. de la Santa Creu i Sant Pau
– sequence: 28
  givenname: David
  surname: Sánchez Lorente
  fullname: Sánchez Lorente, David
  organization: H. Clinic de Barcelona
– sequence: 29
  givenname: Mariano
  orcidid: 0000-0001-9053-9197
  surname: Provencio
  fullname: Provencio, Mariano
  email: mariano.provencio@uam.es
  organization: Head of the Oncology Department at the Hospital Universitario Puerta de Hierro. Full Professor of Medicine, Universidad Autónoma de Madrid, Universidad Autónoma de Madrid
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38530556$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1v1DAQtVAR_YA_wAH5WA4Bf8SJzQWhqF2QtgWpcLYcx9l15bWDnVTsr-Av12lKVXrowePRzHszo_eOwYEP3gDwFqMPGKH6Y8IEibJAJD9KOSn2L8ARroQoKGLs4FF-CI5TukY5qzB-BQ4pZ3O5OgJ_LyY32s4mbQdnvYp7qIYhBqW3sA8RuqCVc7nY3SivTQfzDUXa5RrUJgc3-Q3UcyvC08urZt28_wQJIhSaP4OJI9TBJ-PTlGDo4bg18GpQ3qYtXM_MZmGuYpgGuDprfrwGL3vlknlz_5-AX-dnP5uvxfr76lvzZV3osqzHomZt1wrUMc4F50h1uCWaiqrHmitCGMEMtazFArEsUSW0pp2pMDKiMqauW3oCPi9zh6ndmU4bP0bl5BDtLmsgg7Ly_463W7kJNxJjXPOK0jzh9H5CDL8nk0a5yypmTZQ3YUqSIkRLKnhZZ-i7x8setvyzIQPIAtAxpBRN_wDBSM5ey8Vrmb2Wd17LfSbxJyRtRzXaMB9s3fNUulBT3uM3JsrrMEWfBX-OdQs9br80
CitedBy_id crossref_primary_10_1007_s12094_024_03540_2
crossref_primary_10_1016_j_lungcan_2025_108419
crossref_primary_10_1007_s12094_024_03704_0
Cites_doi 10.1016/j.jtho.2021.09.005
10.21037/tlcr.2019.11.03
10.1200/JCO.21.00174
10.1016/j.athoracsur.2011.03.021
10.1159/000319937
10.1002/cncr.26689
10.1016/j.jtho.2019.08.1533
10.1200/JCO.21.02660
10.1183/09031936.00184308
10.1158/1538-7445.AM2023-CT005
10.1016/j.cllc.2020.06.020
10.1038/s41591-022-01962-5
10.1200/JCO.22.02186
10.1016/j.prro.2015.02.012
10.1093/annonc/mdv187
10.1067/mtc.2001.112465
10.1016/j.athoracsur.2009.04.015
10.1016/j.ejcts.2009.04.003
10.1378/chest.103.4_Supplement.342S
10.1056/NEJMoa1709937
10.1016/j.ccm.2013.06.003
10.1200/JCO.22.00873
10.1200/JCO.19.03136
10.1016/S0003-4975(02)04350-3
10.1200/JCO.2006.05.6341
10.1001/jamaoncol.2021.1910
10.1056/NEJMoa1606774
10.1016/j.jtho.2022.07.014
10.1038/s41591-020-01224-2
10.3322/caac.21660
10.1016/j.athoracsur.2004.07.009
10.1200/JCO.2007.14.9229
10.1001/jamanetworkopen.2023.11966
10.1016/j.jtho.2017.09.1954
10.3322/caac.21654
10.1056/NEJMoa2302983
10.1056/NEJM199711063371907
10.1097/01.JTO.0000263722.22686.1c
10.1016/j.ejcts.2009.11.014
10.1056/NEJMoa1716078
10.1097/JTO.0b013e3182774108
10.1056/NEJMoa1916623
10.1200/JCO.23.01261
10.1136/jitc-2021-002435
10.1055/s-2005-919103
10.1200/JCO.2017.77.6385
10.1056/NEJMoa1910231
10.1016/j.esmoop.2022.100455
10.1097/JTO.0b013e318206a221
10.1200/EDBK_358995
10.1200/JCO.2007.14.1226
10.1007/s12094-021-02712-8
10.1056/NEJMoa2202170
10.1016/j.lungcan.2003.10.013
10.1016/S1470-2045(21)00606-9
10.1378/chest.115.3.714
10.1016/j.jtho.2020.01.005
10.1097/JTO.0b013e3181914d52
10.1093/annonc/mdy041
10.1016/S0140-6736(15)60294-X
10.3322/caac.21708
10.1016/S1470-2045(21)00383-1
10.1097/RTI.0000000000000210
10.1136/jitc-2020-001282
10.7326/0003-4819-151-4-200908180-00132
10.1378/chest.08-2019
10.1056/NEJMoa2215530
10.3322/caac.21388
10.1016/j.jtcvs.2017.01.003
10.1016/j.jtho.2021.02.024
10.1200/JCO.2023.41.16_suppl.8501
10.1016/j.athoracsur.2012.03.018
10.1016/j.jtcvs.2011.08.037
10.1136/thx.2006.072959
10.1200/JCO.19.02748
10.1200/JCO.2014.59.2360
10.1590/S1806-37132015000004466
10.1200/JCO.22.01503
10.1016/S0140-6736(09)60737-6
10.4187/respcare.03779
10.1111/crj.13244
10.1158/2159-8290.CD-16-0577
10.1016/j.athoracsur.2007.03.081
10.1080/13611260500069947
10.1158/1538-7445.AM2018-1719
10.1023/A:1006308808769
10.1016/S0140-6736(18)32409-7
10.7326/M21-0252
10.1016/j.rmed.2004.01.007
10.1200/JCO.2007.13.9030
10.1200/JCO.22.01989
10.1016/S1470-2045(20)30453-8
10.1378/chest.07-1360
10.1510/icvts.2009.211219
10.1016/S1470-2045(20)30641-0
10.1200/JCO.2006.08.2826
10.1080/0142159X.2017.1245856
10.1245/s10434-010-0985-4
10.5114/kitp.2014.45675
10.4103/joacp.JOACP_89_17
10.1186/s12913-021-06511-3
10.1016/j.chest.2021.05.009
10.1378/chest.12-2355
10.1200/JCO.21.02528
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1007/s12094-024-03382-y
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1699-3055
EndPage 1663
ExternalDocumentID PMC11178633
38530556
10_1007_s12094_024_03382_y
Genre Consensus Development Conference
Journal Article
Review
GeographicLocations Spain
GeographicLocations_xml – name: Spain
GrantInformation_xml – fundername: Universidad Autónoma de Madrid
GroupedDBID -05
-0E
-5E
-5G
-BR
-EM
-S~
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29B
29~
2B.
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VR
5VS
67Z
6NX
8TC
8UJ
92I
92M
93N
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACZOJ
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
B-.
BA0
BDATZ
BGNMA
BSONS
C6C
CAG
CCEZO
CHBEP
CIEJG
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
F5P
FA0
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HF~
HG5
HG6
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JUIAU
JZLTJ
KOV
KPH
LLZTM
M4Y
MA-
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P2P
P9S
PF0
PT4
Q--
Q-4
QOR
QOS
R89
R9I
ROL
RPX
RSV
RT5
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
T8U
TCJ
TSG
TSK
TSV
TT1
TUC
U1F
U1G
U2A
U5O
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
YLTOR
Z45
Z7D
Z7U
Z82
Z87
ZMTXR
ZOVNA
~A9
~N8
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c447t-75bdb90d5889880ad1b2c396f1c8a2252150b5b190509469cc3de610e96ee77b3
IEDL.DBID AGYKE
ISSN 1699-3055
1699-048X
IngestDate Thu Aug 21 18:33:33 EDT 2025
Thu Sep 04 16:08:53 EDT 2025
Mon Jul 21 06:03:37 EDT 2025
Thu Apr 24 23:00:34 EDT 2025
Tue Jul 01 03:55:55 EDT 2025
Fri Feb 21 02:40:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Neoadjuvant
Locally advanced NSCLC
Surgery
Immunotherapy
Expert consensus
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c447t-75bdb90d5889880ad1b2c396f1c8a2252150b5b190509469cc3de610e96ee77b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Review-5
ObjectType-News-3
content type line 23
ObjectType-Conference-4
ObjectType-Feature-2
ORCID 0000-0001-9053-9197
OpenAccessLink https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/s12094-024-03382-y
PMID 38530556
PQID 3003439847
PQPubID 23479
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11178633
proquest_miscellaneous_3003439847
pubmed_primary_38530556
crossref_primary_10_1007_s12094_024_03382_y
crossref_citationtrail_10_1007_s12094_024_03382_y
springer_journals_10_1007_s12094_024_03382_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240700
PublicationDateYYYYMMDD 2024-07-01
PublicationDate_xml – month: 7
  year: 2024
  text: 20240700
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Italy
PublicationTitle Clinical & translational oncology
PublicationTitleAbbrev Clin Transl Oncol
PublicationTitleAlternate Clin Transl Oncol
PublicationYear 2024
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References Cascone, William, Weissferdt, Leung, Lin, Pataer (CR61) 2021; 27
Provencio, Nadal, Insa, García-Campelo, Casal-Rubio, Dómine (CR17) 2020; 21
Farjah, Tanner (CR95) 2021; 160
Edge, Compton (CR70) 2010; 17
Amin, Greene, Edge, Compton, Gershenwald, Brookland (CR71) 2017; 67
Arcasoy, Jett (CR42) 1997; 337
Bezjak, Temin, Franklin, Giaccone, Govindan, Johnson (CR102) 2015; 33
CR36
de Villiers, de Villiers, Kent (CR32) 2005; 27
Howlader, Forjaz, Mooradian, Meza, Kong, Cronin (CR4) 2020; 383
Vokes, Ready, Felip, Horn, Burgio, Antonia (CR12) 2018; 29
Hui, Men, Hu, Kang, Sun, Bi (CR100) 2021; 7
Eberhardt, De Ruysscher, Weder, Le Péchoux, De Leyn, Hoffmann (CR59) 2015; 26
Charloux, Brunelli, Bolliger, Rocco, Sculier, Varela (CR88) 2009; 9
Albain, Swann, Rusch, Turrisi, Shepherd, Smith (CR78) 2009; 374
Lee, Port, Korst, Liss, Meherally, Altorki (CR46) 2007; 84
Travis, Dacic, Wistuba, Sholl, Adusumilli, Bubendorf (CR97) 2020; 15
Cerfolio, Bryant (CR83) 2009; 88
Pignon, Tribodet, Scagliotti, Douillard, Shepherd, Stephens (CR5) 2008; 26
Brahmer, Lacchetti, Schneider, Atkins, Brassil, Caterino (CR69) 2018; 36
König, Schär, Vuong, Guckenberger, Furrer, Opitz (CR76) 2022; 7
Aredo, Luo, Gardner, Sanyal, Choi, Hickey (CR107) 2021; 16
Daly, Singh, Ismaila, Antonoff, Arenberg, Bradley (CR60) 2022; 40
Darling, Abdurahman, Yi, Johnston, Waddell, Pierre (CR72) 2005; 79
Singh, Daly, Ismaila, Daly, Singh, Antonoff (CR26) 2023; 41
Guirado, Sanchez-Hernandez, Pijuan, Teixido, Gómez-Caamaño, Cilleruelo-Ramos (CR58) 2022; 24
Shah, Berry, Tzao, Gandhi, Worni, Pietrobon (CR75) 2012; 93
Sun, Noh, Oh, Kim, Lee, Choi (CR101) 2017; 12
Provencio, Nadal, González-Larriba, Martínez-Martí, Bernabé, Bosch-Barrera (CR29) 2023; 389
Annema, Hoekstra, Smit, Veseliç, Versteegh, Rabe (CR47) 2004; 44
Silvestri, Gould, Margolis, Tanoue, McCrory, Toloza (CR49) 2007; 132
De Leyn, Lardinois, Van Schil, Rami-Porta, Passlick, Zielinski (CR45) 2007; 2
Provencio, Serna, Nadal, Glez Larriba, Martínez-Martí, Bernabé (CR62) 2022; 17
Katakami, Tada, Mitsudomi, Kudoh, Senba, Matsui (CR77) 2012; 118
Provencio, Calvo, Romero, Spicer, Cruz-Bermúdez (CR34) 2022; 42
Fielding, Kurimoto (CR50) 2013; 34
Herbst, Wu, John, Grohe, Majem, Wang (CR35) 2023; 41
Rusch, Giroux, Kraut, Crowley, Hazuka, Winton (CR81) 2007; 25
Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal (CR1) 2021; 71
Ohno, Koyama, Lee, Yoshikawa, Sugimura (CR91) 2016; 31
Herth, Annema, Eberhardt, Yasufuku, Ernst, Krasnik (CR93) 2008; 26
Cataldo, Dubey, Prochaska (CR110) 2010; 78
Rodrigues, Choy, Bradley, Rosenzweig, Bogart, Curran (CR106) 2015; 5
Vinod, Wellege, Kim, Duggan, Ibrahim, Shafiq (CR56) 2021; 21
Hwangbo, Kim, Lee, Lee, Kim, Lee (CR51) 2009; 135
Liu, Blake, Yong, Harjunpää, Ngiow, Takeda (CR63) 2016; 6
Dhooria, Aggarwal, Gupta, Behera, Agarwal (CR52) 2015; 60
Schneider, Ismaila, Aerts, Chiles, Daly, Detterbeck (CR98) 2020; 38
Wang (CR85) 2004; 98
Wang, Romero-Gutierrez, Kothari, Shafer, Li, Christiani (CR109) 2023; 6
Provencio, Serna-Blasco, Nadal, Insa, García-Campelo, Casal Rubio (CR30) 2022; 40
Siegel, Miller, Fuchs, Jemal (CR3) 2022; 72
Łapiński, Dziadziuszko, Sawicka, Rzyman (CR80) 2014; 3
Pisters, Evans, Azzoli, Kris, Smith, Desch (CR104) 2007; 25
Stamatis, Fechner, Hillejan, Hinterthaner, Krbek (CR94) 2005; 59
Silvestri, Gonzalez, Jantz, Margolis, Gould, Tanoue (CR55) 2013; 143
Brahmer, Lee, Ciuleanu, Bernabe Caro, Nishio, Urban (CR11) 2023; 41
Garassino, Gadgeel, Speranza, Felip, Esteban, Dómine (CR6) 2023; 41
Sheikh, Mukeriya, Shangina, Brennan, Zaridze (CR108) 2021; 174
Fernández-Bussy, Labarca, Canals, Caviedes, Folch, Majid (CR54) 2015; 41
Roy (CR84) 2018; 34
Schellinger, Meinck, Thron (CR40) 1999; 44
Campelo, Forde, Weder, Spicer, He, Hamid (CR18) 2019; 14
Antonia, Villegas, Daniel, Vicente, Murakami, Hui (CR105) 2017; 377
Rusch, Giroux, Kraut, Crowley, Hazuka, Johnson (CR82) 2001; 121
Bakaeen, Svensson, Mitchell, Keshavjee, Patterson, Weisel (CR31) 2017; 153
De Leyn, Vansteenkiste, Lievens, Van Raemdonck, Nafteux, Decker (CR79) 2009; 4
Sheikhbahaei, Verde, Hales, Rowe, Solnes (CR90) 2020; 21
Pless, Stupp, Ris, Stahel, Weder, Thierstein (CR74) 2015; 386
Heymach, Harpole, Mitsudomi, Taube, Galffy, Hochmair (CR19) 2023; 83
Wakelee, Liberman, Kato, Tsuboi, Lee, Gao (CR20) 2023; 389
Maziak (CR38) 2009; 151
Chaft, Oezkan, Kris, Bunn, Wistuba, Kwiatkowski (CR16) 2022; 28
Reuss, Anagnostou, Cottrell, Smith, Verde, Zahurak (CR66) 2020; 8
Cascone, Hamdi, Zhang, Poteete, Li, Hudgens (CR22) 2018; 78
Mok, Wu, Kudaba, Kowalski, Cho, Turna (CR10) 2019; 393
Siegel, Miller, Fuchs, Jemal (CR2) 2021; 71
Lu, Wu, Zhang, Zhang, Wang, Fang (CR21) 2023; 41
Reck, Rodríguez-Abreu, Robinson, Hui, Csőszi, Fülöp (CR9) 2021; 39
Travis, Brambilla, Noguchi, Nicholson, Geisinger, Yatabe (CR27) 2011; 6
Hellmann, Paz-Ares, Bernabe Caro, Zurawski, Kim, Carcereny Costa (CR13) 2019; 381
Yokoi, Kamiya, Matsuguma, Machida, Hirose, Mori (CR41) 1999; 115
De Leyn, Stroobants, De Wever, Lerut, Coosemans, Decker (CR96) 2006; 24
Forde, Chaft, Smith, Anagnostou, Cottrell, Hellmann (CR67) 2018; 378
William, Pataer, Kalhor, Correa, Rice, Wistuba (CR89) 2013; 8
Reck, Rodríguez-Abreu, Robinson, Hui, Csőszi, Fülöp (CR8) 2016; 375
Billé, Pelosi, Skanjeti, Arena, Errico, Borasio (CR37) 2009; 36
Paz-Ares, Ciuleanu, Cobo, Schenker, Zurawski, Menezes (CR14) 2021; 22
Manenti, Raguso, D’Onofrio, Altobelli, Scarano, Vasili (CR43) 2013; 2013
Yasufuku, Pierre, Darling, de Perrot, Waddell, Johnston (CR44) 2011; 142
Brunelli, Charloux, Bolliger, Rocco, Sculier, Varela (CR87) 2009; 34
Saw, Ong, Chua, Takano, Tan (CR65) 2021; 22
Graeter, Hellwig, Hoffmann, Ukena, Kirsch, Schäfers (CR39) 2003; 75
Reilly, Mentzer, Sugarbaker (CR86) 1993; 103
CR28
Passaro, Attili, de Marinis (CR64) 2022; 40
CR25
Tournoy, Maddens, Gosselin, Van Maele, van Meerbeeck, Kelles (CR48) 2007; 62
CR24
CR23
Heinke, Vinod (CR57) 2020; 9
Forde, Spicer, Lu, Provencio, Mitsudomi, Awad (CR15) 2022; 386
Le Pechoux, Pourel, Barlesi, Lerouge, Antoni, Lamezec (CR99) 2022; 23
Gadgeel, Rodríguez-Abreu, Speranza, Esteban, Felip, Dómine (CR7) 2020; 38
Szlubowski, Herth, Soja, Kołodziej, Figura, Ćmiel (CR92) 2010; 37
Brahmer, Abu-Sbeih, Ascierto, Brufsky, Cappelli, Cortazar (CR68) 2021; 9
Fernandez, Force, Pickens, Kilgo, Luu, Miller (CR73) 2011; 92
Humphrey-Murto, Varpio, Gonsalves, Wood (CR33) 2017; 39
Faivre-Finn, Edwards, Hatton (CR103) 2022; 17
Madan, Mittal, Madan, Tiwari, Jain, Arava (CR53) 2020; 14
WD Travis (3382_CR27) 2011; 6
M Pless (3382_CR74) 2015; 386
EE Vokes (3382_CR12) 2018; 29
S Sheikhbahaei (3382_CR90) 2020; 21
G Rodrigues (3382_CR106) 2015; 5
Y Ohno (3382_CR91) 2016; 31
C Le Pechoux (3382_CR99) 2022; 23
S Gadgeel (3382_CR7) 2020; 38
JJ Reilly (3382_CR86) 1993; 103
PD Schellinger (3382_CR40) 1999; 44
RJ Cerfolio (3382_CR83) 2009; 88
A Szlubowski (3382_CR92) 2010; 37
RG Campelo (3382_CR18) 2019; 14
VW Rusch (3382_CR82) 2001; 121
S Fernández-Bussy (3382_CR54) 2015; 41
JK Cataldo (3382_CR110) 2010; 78
JV Heymach (3382_CR19) 2023; 83
TP Graeter (3382_CR39) 2003; 75
JT Annema (3382_CR47) 2004; 44
3382_CR25
M Łapiński (3382_CR80) 2014; 3
G Stamatis (3382_CR94) 2005; 59
3382_CR24
F Farjah (3382_CR95) 2021; 160
3382_CR23
D König (3382_CR76) 2022; 7
JR Brahmer (3382_CR11) 2023; 41
M Provencio (3382_CR29) 2023; 389
K Madan (3382_CR53) 2020; 14
H Sung (3382_CR1) 2021; 71
3382_CR28
J Liu (3382_CR63) 2016; 6
C Faivre-Finn (3382_CR103) 2022; 17
T Cascone (3382_CR22) 2018; 78
KS Albain (3382_CR78) 2009; 374
M Reck (3382_CR8) 2016; 375
PM Forde (3382_CR15) 2022; 386
WD Travis (3382_CR97) 2020; 15
GE Darling (3382_CR72) 2005; 79
M Sheikh (3382_CR108) 2021; 174
DI Fielding (3382_CR50) 2013; 34
T Cascone (3382_CR61) 2021; 27
3382_CR36
M Guirado (3382_CR58) 2022; 24
JR Brahmer (3382_CR69) 2018; 36
RS Herbst (3382_CR35) 2023; 41
X Wang (3382_CR109) 2023; 6
VW Rusch (3382_CR81) 2007; 25
B Hwangbo (3382_CR51) 2009; 135
M Reck (3382_CR9) 2021; 39
MR de Villiers (3382_CR32) 2005; 27
P De Leyn (3382_CR45) 2007; 2
MD Hellmann (3382_CR13) 2019; 381
A Brunelli (3382_CR87) 2009; 34
KMW Pisters (3382_CR104) 2007; 25
S Lu (3382_CR21) 2023; 41
JV Aredo (3382_CR107) 2021; 16
BJ Schneider (3382_CR98) 2020; 38
G Manenti (3382_CR43) 2013; 2013
K Yokoi (3382_CR41) 1999; 115
K Yasufuku (3382_CR44) 2011; 142
MY Heinke (3382_CR57) 2020; 9
SPL Saw (3382_CR65) 2021; 22
A Billé (3382_CR37) 2009; 36
H Wakelee (3382_CR20) 2023; 389
MC Garassino (3382_CR6) 2023; 41
A Bezjak (3382_CR102) 2015; 33
Z Hui (3382_CR100) 2021; 7
TSK Mok (3382_CR10) 2019; 393
M Provencio (3382_CR34) 2022; 42
JP Pignon (3382_CR5) 2008; 26
GA Silvestri (3382_CR55) 2013; 143
RL Siegel (3382_CR2) 2021; 71
JM Sun (3382_CR101) 2017; 12
PC Lee (3382_CR46) 2007; 84
S Dhooria (3382_CR52) 2015; 60
AA Shah (3382_CR75) 2012; 93
S Humphrey-Murto (3382_CR33) 2017; 39
MB Amin (3382_CR71) 2017; 67
P De Leyn (3382_CR79) 2009; 4
JE Reuss (3382_CR66) 2020; 8
A Passaro (3382_CR64) 2022; 40
M Provencio (3382_CR62) 2022; 17
PM Forde (3382_CR67) 2018; 378
SK Vinod (3382_CR56) 2021; 21
A Charloux (3382_CR88) 2009; 9
RL Siegel (3382_CR3) 2022; 72
JS Wang (3382_CR85) 2004; 98
JE Chaft (3382_CR16) 2022; 28
N Singh (3382_CR26) 2023; 41
FG Bakaeen (3382_CR31) 2017; 153
KG Tournoy (3382_CR48) 2007; 62
GA Silvestri (3382_CR49) 2007; 132
FG Fernandez (3382_CR73) 2011; 92
PM Roy (3382_CR84) 2018; 34
N Howlader (3382_CR4) 2020; 383
M Provencio (3382_CR17) 2020; 21
SB Edge (3382_CR70) 2010; 17
DE Maziak (3382_CR38) 2009; 151
ME Daly (3382_CR60) 2022; 40
L Paz-Ares (3382_CR14) 2021; 22
WN William (3382_CR89) 2013; 8
M Provencio (3382_CR30) 2022; 40
SM Arcasoy (3382_CR42) 1997; 337
FJF Herth (3382_CR93) 2008; 26
WEE Eberhardt (3382_CR59) 2015; 26
P De Leyn (3382_CR96) 2006; 24
N Katakami (3382_CR77) 2012; 118
JR Brahmer (3382_CR68) 2021; 9
SJ Antonia (3382_CR105) 2017; 377
References_xml – volume: 17
  start-page: 197
  issue: 2
  year: 2022
  end-page: 199
  ident: CR103
  article-title: Postoperative radiation therapy should not be used for the therapy of stage III-N2 NSCLC
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2021.09.005
– volume: 9
  start-page: 1639
  issue: 4
  year: 2020
  end-page: 1653
  ident: CR57
  article-title: A review on the impact of lung cancer multidisciplinary care on patient outcomes
  publication-title: Transl Lung Cancer Res
  doi: 10.21037/tlcr.2019.11.03
– volume: 39
  start-page: 2339
  issue: 21
  year: 2021
  end-page: 2349
  ident: CR9
  article-title: Five-year outcomes with pembrolizumab versus chemotherapy for metastatic non–small-cell lung cancer with PD-L1 tumor proportion score ≥ 50%
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.21.00174
– volume: 92
  start-page: 244
  issue: 1
  year: 2011
  end-page: 249
  ident: CR73
  article-title: Impact of laterality on early and late survival after pneumonectomy
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2011.03.021
– volume: 78
  start-page: 289
  issue: 5–6
  year: 2010
  end-page: 301
  ident: CR110
  article-title: Smoking cessation: an integral part of lung cancer treatment
  publication-title: Oncology
  doi: 10.1159/000319937
– volume: 118
  start-page: 6126
  issue: 24
  year: 2012
  end-page: 6135
  ident: CR77
  article-title: A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)
  publication-title: Cancer
  doi: 10.1002/cncr.26689
– volume: 14
  start-page: S719
  issue: 10
  year: 2019
  ident: CR18
  article-title: P2.04–28 NeoCOAST: neoadjuvant durvalumab alone or with novel agents for resectable, early-stage (I–IIIA) non-small cell lung cancer
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2019.08.1533
– volume: 40
  start-page: 2924
  issue: 25
  year: 2022
  end-page: 2933
  ident: CR30
  article-title: Overall survival and biomarker analysis of neoadjuvant nivolumab plus chemotherapy in operable stage IIIA non–small-cell lung cancer (NADIM phase II trial)
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.21.02660
– ident: CR25
– volume: 34
  start-page: 17
  issue: 1
  year: 2009
  end-page: 41
  ident: CR87
  article-title: ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00184308
– volume: 83
  start-page: CT005
  issue: 8_Supplement
  year: 2023
  ident: CR19
  article-title: Abstract CT005: AEGEAN: a phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC
  publication-title: Cancer Res
  doi: 10.1158/1538-7445.AM2023-CT005
– volume: 21
  start-page: 485
  issue: 6
  year: 2020
  end-page: 497
  ident: CR90
  article-title: Imaging in therapy response assessment and surveillance of lung cancer: evidenced-based review with focus on the utility of 18F-FDG PET/CT
  publication-title: Clin Lung Cancer
  doi: 10.1016/j.cllc.2020.06.020
– volume: 28
  start-page: 2155
  issue: 10
  year: 2022
  end-page: 2161
  ident: CR16
  article-title: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
  publication-title: Nat Med
  doi: 10.1038/s41591-022-01962-5
– volume: 41
  start-page: 1830
  issue: 10
  year: 2023
  end-page: 1840
  ident: CR35
  article-title: Adjuvant osimertinib for resected EGFR-mutated stage IB-IIIA non–small-cell lung cancer: updated results from the phase III randomized ADAURA trial
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.22.02186
– volume: 5
  start-page: 141
  issue: 3
  year: 2015
  end-page: 148
  ident: CR106
  article-title: Definitive radiation therapy in locally advanced non-small cell lung cancer: executive summary of an American society for radiation oncology (ASTRO) evidence-based clinical practice guideline
  publication-title: Pract Radiat Oncol
  doi: 10.1016/j.prro.2015.02.012
– volume: 26
  start-page: 1573
  issue: 8
  year: 2015
  end-page: 1588
  ident: CR59
  article-title: 2nd ESMO consensus conference in lung cancer: locally advanced stage III non-small-cell lung cancer
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdv187
– volume: 121
  start-page: 472
  issue: 3
  year: 2001
  end-page: 483
  ident: CR82
  article-title: Induction chemoradiation and surgical resection for non–small cell lung carcinomas of the superior sulcus: initial results of southwest oncology group trial 9416 (Intergroup Trial 0160)
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1067/mtc.2001.112465
– volume: 88
  start-page: 405
  issue: 2
  year: 2009
  end-page: 411
  ident: CR83
  article-title: Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2009.04.015
– volume: 36
  start-page: 440
  issue: 3
  year: 2009
  end-page: 445
  ident: CR37
  article-title: Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography☆
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1016/j.ejcts.2009.04.003
– ident: CR36
– volume: 103
  start-page: 342S
  issue: 4
  year: 1993
  end-page: 345S
  ident: CR86
  article-title: Preoperative assessment of patients undergoing pulmonary resection
  publication-title: Chest
  doi: 10.1378/chest.103.4_Supplement.342S
– volume: 377
  start-page: 1919
  issue: 20
  year: 2017
  end-page: 1929
  ident: CR105
  article-title: Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1709937
– volume: 34
  start-page: 385
  issue: 3
  year: 2013
  end-page: 394
  ident: CR50
  article-title: EBUS-TBNA/staging of lung cancer
  publication-title: Clin Chest Med
  doi: 10.1016/j.ccm.2013.06.003
– volume: 40
  start-page: 2871
  issue: 25
  year: 2022
  end-page: 2877
  ident: CR64
  article-title: Neoadjuvant chemotherapy plus immunotherapy in early-stage resectable non–small-cell lung cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.22.00873
– volume: 38
  start-page: 1505
  issue: 14
  year: 2020
  end-page: 1517
  ident: CR7
  article-title: Updated analysis from KEYNOTE-189: pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non–small-cell lung cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.19.03136
– volume: 75
  start-page: 231
  issue: 1
  year: 2003
  end-page: 236
  ident: CR39
  article-title: Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy
  publication-title: Ann Thorac Surg
  doi: 10.1016/S0003-4975(02)04350-3
– volume: 24
  start-page: 3333
  issue: 21
  year: 2006
  end-page: 3339
  ident: CR96
  article-title: Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non–small-cell lung cancer: a leuven lung cancer group study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.05.6341
– volume: 7
  start-page: 1178
  issue: 8
  year: 2021
  ident: CR100
  article-title: Effect of postoperative radiotherapy for patients with pIIIA-N2 non-small cell lung cancer after complete resection and adjuvant chemotherapy
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2021.1910
– volume: 375
  start-page: 1823
  issue: 19
  year: 2016
  end-page: 1833
  ident: CR8
  article-title: Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1606774
– volume: 17
  start-page: S2
  issue: 9
  year: 2022
  end-page: 3
  ident: CR62
  article-title: PL03.12 progression free survival and overall survival in NADIM II study
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2022.07.014
– volume: 27
  start-page: 504
  issue: 3
  year: 2021
  end-page: 514
  ident: CR61
  article-title: Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
  publication-title: Nat Med
  doi: 10.1038/s41591-020-01224-2
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  end-page: 249
  ident: CR1
  article-title: Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 79
  start-page: 433
  issue: 2
  year: 2005
  end-page: 437
  ident: CR72
  article-title: Risk of a right pneumonectomy: role of bronchopleural fistula
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2004.07.009
– volume: 26
  start-page: 3346
  issue: 20
  year: 2008
  end-page: 3350
  ident: CR93
  article-title: Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.14.9229
– volume: 6
  issue: 5
  year: 2023
  ident: CR109
  article-title: Prediagnosis smoking cessation and overall survival among patients with non-small cell lung cancer
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2023.11966
– volume: 12
  start-page: 1806
  issue: 12
  year: 2017
  end-page: 1813
  ident: CR101
  article-title: Randomized phase II trial comparing chemoradiotherapy with chemotherapy for completely resected unsuspected N2-positive non-small cell lung cancer
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2017.09.1954
– volume: 71
  start-page: 7
  issue: 1
  year: 2021
  end-page: 33
  ident: CR2
  article-title: Cancer statistics, 2021
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21654
– volume: 389
  start-page: 491
  issue: 6
  year: 2023
  end-page: 503
  ident: CR20
  article-title: Perioperative pembrolizumab for early-stage non–small-cell lung cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2302983
– volume: 337
  start-page: 1370
  issue: 19
  year: 1997
  end-page: 1376
  ident: CR42
  article-title: Superior pulmonary sulcus tumors and Pancoast’s syndrome
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199711063371907
– volume: 2
  start-page: 357
  issue: 4
  year: 2007
  end-page: 361
  ident: CR45
  article-title: European trends in preoperative and intraoperative nodal staging: ESTS guidelines
  publication-title: J Thorac Oncol
  doi: 10.1097/01.JTO.0000263722.22686.1c
– volume: 37
  start-page: 1180
  issue: 5
  year: 2010
  end-page: 1184
  ident: CR92
  article-title: Endobronchial ultrasound-guided needle aspiration in non-small-cell lung cancer restaging verified by the transcervical bilateral extended mediastinal lymphadenectomy—a prospective study☆
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1016/j.ejcts.2009.11.014
– volume: 378
  start-page: 1976
  issue: 21
  year: 2018
  end-page: 1986
  ident: CR67
  article-title: Neoadjuvant PD-1 blockade in resectable lung cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1716078
– volume: 8
  start-page: 222
  issue: 2
  year: 2013
  end-page: 228
  ident: CR89
  article-title: Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non–small-cell lung cancer after neoadjuvant chemotherapy
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e3182774108
– volume: 383
  start-page: 640
  issue: 7
  year: 2020
  end-page: 649
  ident: CR4
  article-title: The effect of advances in lung-cancer treatment on population mortality
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1916623
– volume: 41
  start-page: 4430
  issue: 27
  year: 2023
  end-page: 4432
  ident: CR26
  article-title: Management of stage III non–small-cell lung cancer: ASCO guideline rapid recommendation update
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.23.01261
– volume: 9
  issue: 6
  year: 2021
  ident: CR68
  article-title: Society for immunotherapy of cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2021-002435
– volume: 59
  start-page: 862
  issue: 12
  year: 2005
  end-page: 866
  ident: CR94
  article-title: Repeat mediastinoscopy as a restaging procedure
  publication-title: Pneumologie
  doi: 10.1055/s-2005-919103
– volume: 36
  start-page: 1714
  issue: 17
  year: 2018
  end-page: 1768
  ident: CR69
  article-title: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.77.6385
– volume: 381
  start-page: 2020
  issue: 21
  year: 2019
  end-page: 2031
  ident: CR13
  article-title: Nivolumab plus ipilimumab in advanced non–small-cell lung cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1910231
– volume: 7
  issue: 2
  year: 2022
  ident: CR76
  article-title: Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials
  publication-title: ESMO Open
  doi: 10.1016/j.esmoop.2022.100455
– volume: 6
  start-page: 244
  issue: 2
  year: 2011
  end-page: 285
  ident: CR27
  article-title: International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e318206a221
– volume: 42
  start-page: 711
  year: 2022
  end-page: 728
  ident: CR34
  article-title: Treatment sequencing in resectable lung cancer: the good and the bad of adjuvant versus neoadjuvant therapy
  publication-title: Am Soc Clin Oncol Educ Book
  doi: 10.1200/EDBK_358995
– volume: 25
  start-page: 5506
  issue: 34
  year: 2007
  end-page: 5518
  ident: CR104
  article-title: Cancer care Ontario and American society of clinical oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non–small-cell lung cancer guideline
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.14.1226
– ident: CR24
– volume: 24
  start-page: 446
  issue: 3
  year: 2022
  end-page: 459
  ident: CR58
  article-title: Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-021-02712-8
– volume: 386
  start-page: 1973
  issue: 21
  year: 2022
  end-page: 1985
  ident: CR15
  article-title: Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2202170
– volume: 44
  start-page: 53
  issue: 1
  year: 2004
  end-page: 60
  ident: CR47
  article-title: Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2003.10.013
– volume: 23
  start-page: 104
  issue: 1
  year: 2022
  end-page: 114
  ident: CR99
  article-title: Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART, IFCT 0503): an open-label, randomised, phase 3 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(21)00606-9
– volume: 115
  start-page: 714
  issue: 3
  year: 1999
  end-page: 719
  ident: CR41
  article-title: Detection of brain metastasis in potentially operable non-small cell lung cancer
  publication-title: Chest
  doi: 10.1378/chest.115.3.714
– volume: 2013
  start-page: 1
  year: 2013
  end-page: 5
  ident: CR43
  article-title: Pancoast tumor: the role of magnetic resonance imaging
  publication-title: Case Rep Radiol
– volume: 15
  start-page: 709
  issue: 5
  year: 2020
  end-page: 740
  ident: CR97
  article-title: IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2020.01.005
– volume: 4
  start-page: 62
  issue: 1
  year: 2009
  end-page: 68
  ident: CR79
  article-title: Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e3181914d52
– volume: 29
  start-page: 959
  issue: 4
  year: 2018
  end-page: 965
  ident: CR12
  article-title: Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdy041
– volume: 386
  start-page: 1049
  issue: 9998
  year: 2015
  end-page: 1056
  ident: CR74
  article-title: Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)60294-X
– volume: 72
  start-page: 7
  issue: 1
  year: 2022
  end-page: 33
  ident: CR3
  article-title: Cancer statistics, 2022
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21708
– volume: 22
  start-page: e501
  issue: 11
  year: 2021
  end-page: e516
  ident: CR65
  article-title: Revisiting neoadjuvant therapy in non-small-cell lung cancer
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(21)00383-1
– volume: 31
  start-page: 215
  issue: 4
  year: 2016
  end-page: 227
  ident: CR91
  article-title: Magnetic resonance imaging (MRI) and positron emission tomography (PET)/MRI for lung cancer staging
  publication-title: J Thorac Imaging
  doi: 10.1097/RTI.0000000000000210
– volume: 8
  issue: 2
  year: 2020
  ident: CR66
  article-title: Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2020-001282
– volume: 151
  start-page: 221
  issue: 4
  year: 2009
  ident: CR38
  article-title: Positron emission tomography in staging early lung cancer
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-151-4-200908180-00132
– volume: 135
  start-page: 1280
  issue: 5
  year: 2009
  end-page: 1287
  ident: CR51
  article-title: Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer
  publication-title: Chest
  doi: 10.1378/chest.08-2019
– volume: 389
  start-page: 504
  issue: 6
  year: 2023
  end-page: 513
  ident: CR29
  article-title: Perioperative nivolumab and chemotherapy in stage III non–small-cell lung cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2215530
– volume: 67
  start-page: 93
  issue: 2
  year: 2017
  end-page: 99
  ident: CR71
  article-title: The eight edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21388
– volume: 153
  start-page: 999
  issue: 4
  year: 2017
  end-page: 1005
  ident: CR31
  article-title: The American association for thoracic surgery/society of thoracic surgeons position statement on developing clinical practice documents
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2017.01.003
– volume: 16
  start-page: 968
  issue: 6
  year: 2021
  end-page: 979
  ident: CR107
  article-title: Tobacco smoking and risk of second primary lung cancer
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2021.02.024
– volume: 41
  start-page: 8501
  issue: 16_suppl
  year: 2023
  end-page: 8501
  ident: CR21
  article-title: Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): interim event-free survival (EFS) analysis of the phase III NEOTORCH study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2023.41.16_suppl.8501
– volume: 93
  start-page: 1807
  issue: 6
  year: 2012
  end-page: 1812
  ident: CR75
  article-title: Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2012.03.018
– volume: 142
  start-page: 1393
  issue: 6
  year: 2011
  end-page: 1400
  ident: CR44
  article-title: A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2011.08.037
– volume: 62
  start-page: 696
  issue: 8
  year: 2007
  end-page: 701
  ident: CR48
  article-title: Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study
  publication-title: Thorax
  doi: 10.1136/thx.2006.072959
– volume: 38
  start-page: 753
  issue: 7
  year: 2020
  end-page: 766
  ident: CR98
  article-title: Lung cancer surveillance after definitive curative-intent therapy: ASCO guideline
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.19.02748
– volume: 33
  start-page: 2100
  issue: 18
  year: 2015
  end-page: 2105
  ident: CR102
  article-title: Definitive and adjuvant radiotherapy in locally advanced non–small-cell lung cancer: American society of clinical oncology clinical practice guideline endorsement of the American society for radiation oncology evidence-based clinical practice guideline
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2014.59.2360
– volume: 41
  start-page: 219
  issue: 3
  year: 2015
  end-page: 224
  ident: CR54
  article-title: Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging in lung cancer
  publication-title: J Bras Pneumol
  doi: 10.1590/S1806-37132015000004466
– volume: 41
  start-page: 1200
  issue: 6
  year: 2023
  end-page: 1212
  ident: CR11
  article-title: Five-year survival outcomes with nivolumab plus ipilimumab versus chemotherapy as first-line treatment for metastatic non–small-cell lung cancer in CheckMate 227
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.22.01503
– volume: 374
  start-page: 379
  issue: 9687
  year: 2009
  end-page: 386
  ident: CR78
  article-title: Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(09)60737-6
– volume: 60
  start-page: 1040
  issue: 7
  year: 2015
  end-page: 1050
  ident: CR52
  article-title: Utility and safety of endoscopic ultrasound with bronchoscope-guided fine-needle aspiration in mediastinal lymph node sampling: systematic review and meta-analysis
  publication-title: Respir Care
  doi: 10.4187/respcare.03779
– volume: 14
  start-page: 1076
  issue: 11
  year: 2020
  end-page: 1082
  ident: CR53
  article-title: EBUS-TBNA versus EUS-B-FNA for the evaluation of undiagnosed mediastinal lymphadenopathy: the TEAM randomized controlled trial
  publication-title: Clin Respir J
  doi: 10.1111/crj.13244
– volume: 6
  start-page: 1382
  issue: 12
  year: 2016
  end-page: 1399
  ident: CR63
  article-title: Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-16-0577
– volume: 84
  start-page: 177
  issue: 1
  year: 2007
  end-page: 181
  ident: CR46
  article-title: Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2007.03.081
– volume: 27
  start-page: 639
  issue: 7
  year: 2005
  end-page: 643
  ident: CR32
  article-title: The Delphi technique in health sciences education research
  publication-title: Med Teach
  doi: 10.1080/13611260500069947
– volume: 78
  start-page: 1719
  issue: 13_Supplement
  year: 2018
  ident: CR22
  article-title: Abstract 1719: Superior efficacy of neoadjuvant compared to adjuvant immune checkpoint blockade in non-small cell lung cancer
  publication-title: Cancer Res
  doi: 10.1158/1538-7445.AM2018-1719
– volume: 44
  start-page: 275
  issue: 3
  year: 1999
  end-page: 281
  ident: CR40
  article-title: Diagnostic accuracy of MRI compared to CCT in patients with brain metastases
  publication-title: J Neurooncol
  doi: 10.1023/A:1006308808769
– volume: 393
  start-page: 1819
  issue: 10183
  year: 2019
  end-page: 1830
  ident: CR10
  article-title: Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32409-7
– volume: 174
  start-page: 1232
  issue: 9
  year: 2021
  end-page: 1239
  ident: CR108
  article-title: Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality
  publication-title: Ann Intern Med
  doi: 10.7326/M21-0252
– volume: 98
  start-page: 598
  issue: 7
  year: 2004
  end-page: 605
  ident: CR85
  article-title: Pulmonary function tests in preoperative pulmonary evaluation
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2004.01.007
– volume: 26
  start-page: 3552
  issue: 21
  year: 2008
  end-page: 3559
  ident: CR5
  article-title: Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.13.9030
– volume: 41
  start-page: 1992
  issue: 11
  year: 2023
  end-page: 1998
  ident: CR6
  article-title: Pembrolizumab plus pemetrexed and platinum in nonsquamous non–small-cell lung cancer: 5-year outcomes from the phase 3 KEYNOTE-189 study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.22.01989
– volume: 21
  start-page: 1413
  issue: 11
  year: 2020
  end-page: 1422
  ident: CR17
  article-title: Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30453-8
– volume: 132
  start-page: 178S
  issue: 3
  year: 2007
  end-page: 201S
  ident: CR49
  article-title: Noninvasive staging of non-small cell lung cancer
  publication-title: Chest
  doi: 10.1378/chest.07-1360
– volume: 9
  start-page: 925
  issue: 6
  year: 2009
  end-page: 931
  ident: CR88
  article-title: Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory Society (ERS)
  publication-title: Interact Cardiovasc Thorac Surg
  doi: 10.1510/icvts.2009.211219
– volume: 22
  start-page: 198
  issue: 2
  year: 2021
  end-page: 211
  ident: CR14
  article-title: First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30641-0
– ident: CR23
– volume: 25
  start-page: 313
  issue: 3
  year: 2007
  end-page: 318
  ident: CR81
  article-title: Induction chemoradiation and surgical resection for superior sulcus non–small-cell lung carcinomas: long-term results of southwest oncology group trial 9416 (Intergroup Trial 0160)
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.08.2826
– volume: 39
  start-page: 14
  issue: 1
  year: 2017
  end-page: 19
  ident: CR33
  article-title: Using consensus group methods such as Delphi and Nominal Group in medical education research
  publication-title: Med Teach
  doi: 10.1080/0142159X.2017.1245856
– volume: 17
  start-page: 1471
  issue: 6
  year: 2010
  end-page: 1474
  ident: CR70
  article-title: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-010-0985-4
– volume: 3
  start-page: 268
  year: 2014
  end-page: 272
  ident: CR80
  article-title: THORACIC SURGERY early results of a trimodality treatment for superior sulcus tumors
  publication-title: Polish J Cardio Thorac Surg
  doi: 10.5114/kitp.2014.45675
– volume: 34
  start-page: 296
  issue: 3
  year: 2018
  end-page: 300
  ident: CR84
  article-title: Preoperative pulmonary evaluation for lung resection
  publication-title: J Anaesthesiol Clin Pharmacol
  doi: 10.4103/joacp.JOACP_89_17
– volume: 21
  start-page: 461
  issue: 1
  year: 2021
  ident: CR56
  article-title: Translation of oncology multidisciplinary team meeting (MDM) recommendations into clinical practice
  publication-title: BMC Health Serv Res
  doi: 10.1186/s12913-021-06511-3
– volume: 160
  start-page: 1552
  issue: 4
  year: 2021
  end-page: 1559
  ident: CR95
  article-title: Mediastinal staging for lung cancer
  publication-title: Chest
  doi: 10.1016/j.chest.2021.05.009
– volume: 143
  start-page: e211S
  issue: 5
  year: 2013
  end-page: e250S
  ident: CR55
  article-title: Methods for staging non-small cell lung cancer
  publication-title: Chest
  doi: 10.1378/chest.12-2355
– ident: CR28
– volume: 40
  start-page: 1356
  issue: 12
  year: 2022
  end-page: 1384
  ident: CR60
  article-title: Management of stage III non–small-cell lung cancer: ASCO guideline
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.21.02528
– volume: 2013
  start-page: 1
  year: 2013
  ident: 3382_CR43
  publication-title: Case Rep Radiol
– volume: 59
  start-page: 862
  issue: 12
  year: 2005
  ident: 3382_CR94
  publication-title: Pneumologie
  doi: 10.1055/s-2005-919103
– volume: 21
  start-page: 1413
  issue: 11
  year: 2020
  ident: 3382_CR17
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30453-8
– volume: 121
  start-page: 472
  issue: 3
  year: 2001
  ident: 3382_CR82
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1067/mtc.2001.112465
– volume: 98
  start-page: 598
  issue: 7
  year: 2004
  ident: 3382_CR85
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2004.01.007
– volume: 75
  start-page: 231
  issue: 1
  year: 2003
  ident: 3382_CR39
  publication-title: Ann Thorac Surg
  doi: 10.1016/S0003-4975(02)04350-3
– volume: 40
  start-page: 2871
  issue: 25
  year: 2022
  ident: 3382_CR64
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.22.00873
– volume: 34
  start-page: 385
  issue: 3
  year: 2013
  ident: 3382_CR50
  publication-title: Clin Chest Med
  doi: 10.1016/j.ccm.2013.06.003
– volume: 79
  start-page: 433
  issue: 2
  year: 2005
  ident: 3382_CR72
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2004.07.009
– volume: 25
  start-page: 5506
  issue: 34
  year: 2007
  ident: 3382_CR104
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.14.1226
– volume: 92
  start-page: 244
  issue: 1
  year: 2011
  ident: 3382_CR73
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2011.03.021
– volume: 23
  start-page: 104
  issue: 1
  year: 2022
  ident: 3382_CR99
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(21)00606-9
– volume: 4
  start-page: 62
  issue: 1
  year: 2009
  ident: 3382_CR79
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e3181914d52
– volume: 6
  start-page: 244
  issue: 2
  year: 2011
  ident: 3382_CR27
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e318206a221
– volume: 36
  start-page: 1714
  issue: 17
  year: 2018
  ident: 3382_CR69
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.77.6385
– volume: 9
  issue: 6
  year: 2021
  ident: 3382_CR68
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2021-002435
– volume: 27
  start-page: 504
  issue: 3
  year: 2021
  ident: 3382_CR61
  publication-title: Nat Med
  doi: 10.1038/s41591-020-01224-2
– volume: 103
  start-page: 342S
  issue: 4
  year: 1993
  ident: 3382_CR86
  publication-title: Chest
  doi: 10.1378/chest.103.4_Supplement.342S
– volume: 17
  start-page: 1471
  issue: 6
  year: 2010
  ident: 3382_CR70
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-010-0985-4
– volume: 26
  start-page: 3552
  issue: 21
  year: 2008
  ident: 3382_CR5
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.13.9030
– volume: 26
  start-page: 3346
  issue: 20
  year: 2008
  ident: 3382_CR93
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.14.9229
– ident: 3382_CR25
– volume: 142
  start-page: 1393
  issue: 6
  year: 2011
  ident: 3382_CR44
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2011.08.037
– volume: 151
  start-page: 221
  issue: 4
  year: 2009
  ident: 3382_CR38
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-151-4-200908180-00132
– volume: 5
  start-page: 141
  issue: 3
  year: 2015
  ident: 3382_CR106
  publication-title: Pract Radiat Oncol
  doi: 10.1016/j.prro.2015.02.012
– volume: 153
  start-page: 999
  issue: 4
  year: 2017
  ident: 3382_CR31
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2017.01.003
– volume: 337
  start-page: 1370
  issue: 19
  year: 1997
  ident: 3382_CR42
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199711063371907
– volume: 27
  start-page: 639
  issue: 7
  year: 2005
  ident: 3382_CR32
  publication-title: Med Teach
  doi: 10.1080/13611260500069947
– volume: 83
  start-page: CT005
  issue: 8_Supplement
  year: 2023
  ident: 3382_CR19
  publication-title: Cancer Res
  doi: 10.1158/1538-7445.AM2023-CT005
– volume: 2
  start-page: 357
  issue: 4
  year: 2007
  ident: 3382_CR45
  publication-title: J Thorac Oncol
  doi: 10.1097/01.JTO.0000263722.22686.1c
– volume: 374
  start-page: 379
  issue: 9687
  year: 2009
  ident: 3382_CR78
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(09)60737-6
– volume: 393
  start-page: 1819
  issue: 10183
  year: 2019
  ident: 3382_CR10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32409-7
– volume: 14
  start-page: S719
  issue: 10
  year: 2019
  ident: 3382_CR18
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2019.08.1533
– volume: 14
  start-page: 1076
  issue: 11
  year: 2020
  ident: 3382_CR53
  publication-title: Clin Respir J
  doi: 10.1111/crj.13244
– volume: 6
  issue: 5
  year: 2023
  ident: 3382_CR109
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2023.11966
– volume: 21
  start-page: 485
  issue: 6
  year: 2020
  ident: 3382_CR90
  publication-title: Clin Lung Cancer
  doi: 10.1016/j.cllc.2020.06.020
– volume: 71
  start-page: 209
  issue: 3
  year: 2021
  ident: 3382_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 62
  start-page: 696
  issue: 8
  year: 2007
  ident: 3382_CR48
  publication-title: Thorax
  doi: 10.1136/thx.2006.072959
– volume: 386
  start-page: 1049
  issue: 9998
  year: 2015
  ident: 3382_CR74
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)60294-X
– volume: 9
  start-page: 1639
  issue: 4
  year: 2020
  ident: 3382_CR57
  publication-title: Transl Lung Cancer Res
  doi: 10.21037/tlcr.2019.11.03
– volume: 16
  start-page: 968
  issue: 6
  year: 2021
  ident: 3382_CR107
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2021.02.024
– volume: 7
  start-page: 1178
  issue: 8
  year: 2021
  ident: 3382_CR100
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2021.1910
– volume: 12
  start-page: 1806
  issue: 12
  year: 2017
  ident: 3382_CR101
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2017.09.1954
– volume: 174
  start-page: 1232
  issue: 9
  year: 2021
  ident: 3382_CR108
  publication-title: Ann Intern Med
  doi: 10.7326/M21-0252
– volume: 25
  start-page: 313
  issue: 3
  year: 2007
  ident: 3382_CR81
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.08.2826
– volume: 381
  start-page: 2020
  issue: 21
  year: 2019
  ident: 3382_CR13
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1910231
– volume: 40
  start-page: 2924
  issue: 25
  year: 2022
  ident: 3382_CR30
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.21.02660
– volume: 33
  start-page: 2100
  issue: 18
  year: 2015
  ident: 3382_CR102
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2014.59.2360
– volume: 72
  start-page: 7
  issue: 1
  year: 2022
  ident: 3382_CR3
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21708
– volume: 24
  start-page: 3333
  issue: 21
  year: 2006
  ident: 3382_CR96
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.05.6341
– volume: 28
  start-page: 2155
  issue: 10
  year: 2022
  ident: 3382_CR16
  publication-title: Nat Med
  doi: 10.1038/s41591-022-01962-5
– volume: 115
  start-page: 714
  issue: 3
  year: 1999
  ident: 3382_CR41
  publication-title: Chest
  doi: 10.1378/chest.115.3.714
– volume: 24
  start-page: 446
  issue: 3
  year: 2022
  ident: 3382_CR58
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-021-02712-8
– volume: 31
  start-page: 215
  issue: 4
  year: 2016
  ident: 3382_CR91
  publication-title: J Thorac Imaging
  doi: 10.1097/RTI.0000000000000210
– volume: 17
  start-page: S2
  issue: 9
  year: 2022
  ident: 3382_CR62
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2022.07.014
– volume: 67
  start-page: 93
  issue: 2
  year: 2017
  ident: 3382_CR71
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21388
– volume: 41
  start-page: 219
  issue: 3
  year: 2015
  ident: 3382_CR54
  publication-title: J Bras Pneumol
  doi: 10.1590/S1806-37132015000004466
– volume: 37
  start-page: 1180
  issue: 5
  year: 2010
  ident: 3382_CR92
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1016/j.ejcts.2009.11.014
– volume: 383
  start-page: 640
  issue: 7
  year: 2020
  ident: 3382_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1916623
– ident: 3382_CR24
– volume: 17
  start-page: 197
  issue: 2
  year: 2022
  ident: 3382_CR103
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2021.09.005
– volume: 39
  start-page: 2339
  issue: 21
  year: 2021
  ident: 3382_CR9
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.21.00174
– volume: 39
  start-page: 14
  issue: 1
  year: 2017
  ident: 3382_CR33
  publication-title: Med Teach
  doi: 10.1080/0142159X.2017.1245856
– volume: 8
  start-page: 222
  issue: 2
  year: 2013
  ident: 3382_CR89
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e3182774108
– volume: 15
  start-page: 709
  issue: 5
  year: 2020
  ident: 3382_CR97
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2020.01.005
– volume: 44
  start-page: 53
  issue: 1
  year: 2004
  ident: 3382_CR47
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2003.10.013
– volume: 386
  start-page: 1973
  issue: 21
  year: 2022
  ident: 3382_CR15
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2202170
– volume: 41
  start-page: 8501
  issue: 16_suppl
  year: 2023
  ident: 3382_CR21
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2023.41.16_suppl.8501
– volume: 88
  start-page: 405
  issue: 2
  year: 2009
  ident: 3382_CR83
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2009.04.015
– volume: 38
  start-page: 1505
  issue: 14
  year: 2020
  ident: 3382_CR7
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.19.03136
– volume: 389
  start-page: 491
  issue: 6
  year: 2023
  ident: 3382_CR20
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2302983
– volume: 6
  start-page: 1382
  issue: 12
  year: 2016
  ident: 3382_CR63
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-16-0577
– volume: 160
  start-page: 1552
  issue: 4
  year: 2021
  ident: 3382_CR95
  publication-title: Chest
  doi: 10.1016/j.chest.2021.05.009
– volume: 78
  start-page: 289
  issue: 5–6
  year: 2010
  ident: 3382_CR110
  publication-title: Oncology
  doi: 10.1159/000319937
– volume: 8
  issue: 2
  year: 2020
  ident: 3382_CR66
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2020-001282
– volume: 9
  start-page: 925
  issue: 6
  year: 2009
  ident: 3382_CR88
  publication-title: Interact Cardiovasc Thorac Surg
  doi: 10.1510/icvts.2009.211219
– volume: 41
  start-page: 1200
  issue: 6
  year: 2023
  ident: 3382_CR11
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.22.01503
– volume: 143
  start-page: e211S
  issue: 5
  year: 2013
  ident: 3382_CR55
  publication-title: Chest
  doi: 10.1378/chest.12-2355
– volume: 41
  start-page: 1830
  issue: 10
  year: 2023
  ident: 3382_CR35
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.22.02186
– volume: 132
  start-page: 178S
  issue: 3
  year: 2007
  ident: 3382_CR49
  publication-title: Chest
  doi: 10.1378/chest.07-1360
– volume: 21
  start-page: 461
  issue: 1
  year: 2021
  ident: 3382_CR56
  publication-title: BMC Health Serv Res
  doi: 10.1186/s12913-021-06511-3
– volume: 34
  start-page: 296
  issue: 3
  year: 2018
  ident: 3382_CR84
  publication-title: J Anaesthesiol Clin Pharmacol
  doi: 10.4103/joacp.JOACP_89_17
– volume: 84
  start-page: 177
  issue: 1
  year: 2007
  ident: 3382_CR46
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2007.03.081
– volume: 22
  start-page: 198
  issue: 2
  year: 2021
  ident: 3382_CR14
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30641-0
– volume: 26
  start-page: 1573
  issue: 8
  year: 2015
  ident: 3382_CR59
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdv187
– ident: 3382_CR36
– volume: 36
  start-page: 440
  issue: 3
  year: 2009
  ident: 3382_CR37
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1016/j.ejcts.2009.04.003
– volume: 377
  start-page: 1919
  issue: 20
  year: 2017
  ident: 3382_CR105
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1709937
– volume: 41
  start-page: 1992
  issue: 11
  year: 2023
  ident: 3382_CR6
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.22.01989
– volume: 71
  start-page: 7
  issue: 1
  year: 2021
  ident: 3382_CR2
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21654
– volume: 389
  start-page: 504
  issue: 6
  year: 2023
  ident: 3382_CR29
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2215530
– volume: 41
  start-page: 4430
  issue: 27
  year: 2023
  ident: 3382_CR26
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.23.01261
– volume: 118
  start-page: 6126
  issue: 24
  year: 2012
  ident: 3382_CR77
  publication-title: Cancer
  doi: 10.1002/cncr.26689
– volume: 29
  start-page: 959
  issue: 4
  year: 2018
  ident: 3382_CR12
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdy041
– volume: 38
  start-page: 753
  issue: 7
  year: 2020
  ident: 3382_CR98
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.19.02748
– volume: 78
  start-page: 1719
  issue: 13_Supplement
  year: 2018
  ident: 3382_CR22
  publication-title: Cancer Res
  doi: 10.1158/1538-7445.AM2018-1719
– ident: 3382_CR23
– volume: 7
  issue: 2
  year: 2022
  ident: 3382_CR76
  publication-title: ESMO Open
  doi: 10.1016/j.esmoop.2022.100455
– volume: 40
  start-page: 1356
  issue: 12
  year: 2022
  ident: 3382_CR60
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.21.02528
– volume: 34
  start-page: 17
  issue: 1
  year: 2009
  ident: 3382_CR87
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00184308
– volume: 42
  start-page: 711
  year: 2022
  ident: 3382_CR34
  publication-title: Am Soc Clin Oncol Educ Book
  doi: 10.1200/EDBK_358995
– volume: 375
  start-page: 1823
  issue: 19
  year: 2016
  ident: 3382_CR8
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1606774
– volume: 3
  start-page: 268
  year: 2014
  ident: 3382_CR80
  publication-title: Polish J Cardio Thorac Surg
  doi: 10.5114/kitp.2014.45675
– volume: 60
  start-page: 1040
  issue: 7
  year: 2015
  ident: 3382_CR52
  publication-title: Respir Care
  doi: 10.4187/respcare.03779
– volume: 378
  start-page: 1976
  issue: 21
  year: 2018
  ident: 3382_CR67
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1716078
– volume: 44
  start-page: 275
  issue: 3
  year: 1999
  ident: 3382_CR40
  publication-title: J Neurooncol
  doi: 10.1023/A:1006308808769
– volume: 93
  start-page: 1807
  issue: 6
  year: 2012
  ident: 3382_CR75
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2012.03.018
– ident: 3382_CR28
– volume: 22
  start-page: e501
  issue: 11
  year: 2021
  ident: 3382_CR65
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(21)00383-1
– volume: 135
  start-page: 1280
  issue: 5
  year: 2009
  ident: 3382_CR51
  publication-title: Chest
  doi: 10.1378/chest.08-2019
SSID ssj0055611
Score 2.371387
SecondaryResourceType review_article
Snippet Introduction Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the...
Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1647
SubjectTerms Carcinoma, Non-Small-Cell Lung - pathology
Carcinoma, Non-Small-Cell Lung - therapy
Consensus
Delphi Technique
Humans
Lung Neoplasms - pathology
Lung Neoplasms - therapy
Medicine
Medicine & Public Health
Neoplasm Staging
Oncology
Patient Care Team
Research Article
Spain
Title Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
URI https://link.springer.com/article/10.1007/s12094-024-03382-y
https://www.ncbi.nlm.nih.gov/pubmed/38530556
https://www.proquest.com/docview/3003439847
https://pubmed.ncbi.nlm.nih.gov/PMC11178633
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwED6xTUK8wPg1AqMyEg8gyJTESezsrYvaTbBVSKPSeIpix9MmSoqW9GH8E_zLu3Ocjm5o0h6ah8SuHOd899l39x3A-1KY1MQlHYEFAW5QeOlnQRL4VaIQ8UdGmpLOO44m6cE0_nKSnLiksKaPdu9dklZTXye7RQHR2Eb4w31V5F-uwUaCGxRcjhvD_R9fR70GpoqPoUuQ-X_PVSN0C1neDpC84SW1xmf8BKb9sLuYk587i1bt6D83GB3v-16b8NihUTbsxOcpPDD1M3h45Pztz-Gvzc_9N3OX9STkDNEus5ZwhjddJAGr57Xf_MJ7jDwCbIaqhGl6dME-TI7zw_zjLqNS6sxWFmiZpmDuulk0bH7KEIuyY9RO580ZO6SeedfTno-x_VH-7QVMx6Pv-YHvSjj4Oo5F64tEVSoLqkTKDDVFWYUq0jxLT0MtS1QlCDgClaiQ5CPDnbrWvDKI6EyWGiOE4i9hHUduXgGrhOCCG1XKSsUakanUUgvyKyplpNAehP03LbTjN6cyG7PimpmZZrrAmS7sTBeXHnxa9vndsXvc2fpdLyoFLkKax7I280VTcKL54Rlaeg-2OtFZ_h9HQEQi6YFcEaplAyL4Xn1Sn59Zom-0Q0KmnHvwuRedwqmY5o5xvr5f8zfwKLLSRzHI27DeXizMW0RarRrgwhrv7U0GboENYC1Pc7xOo-EV5ugkOw
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5RkNpeKugzLaVTqYdWrUWyTmKHG4qAbdldVQIkblbsGIG0XSqye-BX9C93xpssXaiQuPoRWRmP55sZz2eAT5XyuU8rDoHFMTkoshJFnMWiziwh_p7XvuJ4x3CU90_SH6fZaUuTw7Uwt_L32w3XdqaCLImIyZvqietHsMaZS-bJL_OyO3X5lcekLYr5_7xlw3MHTd69FHkrMxoMzv46PGuRIu7ORbsBK37yHB4P21z4C_gTamf_rarFjiAcCYlisFJjamyz_EiOvmh-URtytB7HpObouOsKP4-OykH5ZQf5mXMMrP9TdHzRetLMGrw8Q8KJeEQnx0VzjgOeWc5nhtgVHuyVP1_Cyf7ecdkX7fMKwqWpmgqV2doWcZ1pXZAWV3Vie04W-VnidEVqTmAgtplNWHYFedHOydoT2vJF7r1SVr6CVVq5fwNYKyWV9LbStU0doUbttFOc87PWa-UiSLp_b1zLPc5PYIzNDWsyy8uQvEyQl7mO4Otizu8588a9oz92IjWkIPwfq4m_nDVGMgWPLMgKR_B6LuLF9ySBFd46Eegl4S8GMPn2cs_k4jyQcJONUDqXMoJv3T4xrfo396zz7cOGf4An_ePhwAy-jw7fwdNe2M98V3gTVqdXM_-eENHUbgVV-AutJgKJ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB61i4R6KfQd6MOVemjVBpI4iR1uKN2FlmWFRJHgZMWOV6AuWUSyB_on-pc7k8fCQoVU9ZCLH1HsjMefPTPfAHzIhI1tmNEVmOfhAYVnbuJFnptHGhF_YKXN6L5jfxTvHoXfj6PjG1H8tbd7Z5JsYhqIpamoNi_y8eZ14FvgEaVtgA-esQL36iEshZRDogdL2zsne_1OG1P2R78Nlvl7z8UN6Q7KvOssectiWm9EgxXIuiE0_ic_N2aV3jC_brE7_s8YV-Fxi1LZdiNWT-CBLZ7C8n5rh38Gv-u43ZsRvawjJ2eIglm9Q06wsPUwYMW0cMtzLGNkKWATVDHMUNUl-zg6TIfppy1GKdZZnXGgYoacvItyVrLpmCFGZYeotc7KUzaknmnTs743Yzv99OA5HA36P9Jdt03t4JowFJUrIp3rxMsjKRPUIFnu68DwJB77RmaoYhCIeDrSPslNgid4Y3huEenZJLZWCM1fQA-_3L4ClgvBBbc6k7kODSJWaaQRZG_U2kphHPC7_6tMy3tO6Tcm6pqxmWZa4UyreqbVlQOf530uGtaPe1u_78RG4eKkecwKO52VihP9D08QATjwshGj-fs4AiUSTwfkgoDNGxDx92JNcXZaE4Dj_iRkzLkDXzoxUq3qKe_5zrV_a_4Olg--DtTw22hvHR4FtSCSm_Jr6FWXM_sGwVil37br7Q_wFSzF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multidisciplinary+approach+for+locally+advanced+non-small+cell+lung+cancer+%28NSCLC%29%3A+2023+expert+consensus+of+the+Spanish+Lung+Cancer+Group+GECP&rft.jtitle=Clinical+%26+translational+oncology&rft.au=Ospina%2C+Aylen+Vanessa&rft.au=Bolufer+Nadal%2C+Sergio&rft.au=Campo-Ca%C3%B1averal+de+la+Cruz%2C+Jos%C3%A9+Luis&rft.au=Gonz%C3%A1lez+Larriba%2C+Jose+Luis&rft.date=2024-07-01&rft.issn=1699-3055&rft.eissn=1699-3055&rft.volume=26&rft.issue=7&rft.spage=1647&rft.epage=1663&rft_id=info:doi/10.1007%2Fs12094-024-03382-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s12094_024_03382_y
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1699-3055&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1699-3055&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1699-3055&client=summon